BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

NCT02155088 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: BYL719
DRUG: Gemcitabine
DRUG: (nab)-paclitaxel

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]